Division of Cardiology, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, 693-8501, Japan.
Clinical Laboratory Division, Faculty of Medicine, Shimane University, 89-1 Enya-cho, Izumo, 693-8501, Japan.
BMC Cardiovasc Disord. 2022 Sep 12;22(1):408. doi: 10.1186/s12872-022-02850-z.
Stent thrombosis (ST) is a serious complication; however, a method to prevent ST in patients with thrombophilic diseases has not been established.
We report a case of subacute ST in a patient with paroxysmal nocturnal hemoglobinuria (PNH) who was receiving continuous heparin treatment in addition to the usual dual antiplatelet therapy for contrast defects at the proximal site of the occluded right coronary artery and the proximal site of the left circumflex artery. Despite the resolution of thrombi in secondary lesions, subacute ST occurred. After percutaneous coronary intervention for ST, triple therapy, including oral anticoagulation for PNH-related thrombosis, was initiated. The patient subsequently underwent craniotomy hematoma removal for hemorrhagic cerebral infarction.
Reported cases of ST in patients with PNH are very few, and this case adds evidence with respect to antithrombotic therapy in patients with thrombotic tendencies. Both thrombosis and bleeding should be considered when administering antithrombotic therapy to patients with thrombotic diseases. If there are specific treatments for thrombophilic diseases, they should be initiated early.
支架血栓形成(ST)是一种严重的并发症;然而,对于血栓形成性疾病患者,尚未建立预防 ST 的方法。
我们报告了一例阵发性夜间血红蛋白尿(PNH)患者的亚急性 ST,该患者在接受常规定期双联抗血小板治疗的基础上,还接受了持续肝素治疗,以治疗闭塞的右冠状动脉近端和左回旋支近端的对比缺陷。尽管继发病变中的血栓已溶解,但仍发生了亚急性 ST。ST 行经皮冠状动脉介入治疗后,开始三联治疗,包括针对 PNH 相关血栓的口服抗凝治疗。随后,该患者因出血性脑梗死而行开颅血肿清除术。
报道的 PNH 患者 ST 病例非常少,本病例为血栓倾向患者的抗血栓治疗提供了证据。对血栓性疾病患者进行抗血栓治疗时,应同时考虑血栓形成和出血。如果有针对血栓形成性疾病的具体治疗方法,应尽早开始。